These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 37748861)

  • 1. ALS-Associated KIF5A Mutation Causes Locomotor Deficits Associated with Cytoplasmic Inclusions, Alterations of Neuromuscular Junctions, and Motor Neuron Loss.
    Soustelle L; Aimond F; López-Andrés C; Brugioti V; Raoul C; Layalle S
    J Neurosci; 2023 Nov; 43(47):8058-8072. PubMed ID: 37748861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ALS-associated KIF5A P986L variant is not pathogenic for Drosophila motoneurons.
    Layalle S; Aimond F; Brugioti V; Guissart C; Raoul C; Soustelle L
    Sci Rep; 2024 Aug; 14(1):19540. PubMed ID: 39174694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired motor unit recovery and maintenance in a knock-in mouse model of ALS-associated Kif5a variant.
    Rich KA; Pino MG; Yalvac ME; Fox A; Harris H; Balch MHH; Arnold WD; Kolb SJ
    Neurobiol Dis; 2023 Jun; 182():106148. PubMed ID: 37164288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneous splicing patterns resulting from KIF5A variants associated with amyotrophic lateral sclerosis.
    Pino MG; Rich KA; Hall NJ; Jones ML; Fox A; Musier-Forsyth K; Kolb SJ
    Hum Mol Genet; 2023 Nov; 32(22):3166-3180. PubMed ID: 37593923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALS-linked KIF5A ΔExon27 mutant causes neuronal toxicity through gain-of-function.
    Pant DC; Parameswaran J; Rao L; Loss I; Chilukuri G; Parlato R; Shi L; Glass JD; Bassell GJ; Koch P; Yilmaz R; Weishaupt JH; Gennerich A; Jiang J
    EMBO Rep; 2022 Aug; 23(8):e54234. PubMed ID: 35735139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALS-associated KIF5A mutations abolish autoinhibition resulting in a toxic gain of function.
    Baron DM; Fenton AR; Saez-Atienzar S; Giampetruzzi A; Sreeram A; Shankaracharya ; Keagle PJ; Doocy VR; Smith NJ; Danielson EW; Andresano M; McCormack MC; Garcia J; Bercier V; Van Den Bosch L; Brent JR; Fallini C; Traynor BJ; Holzbaur ELF; Landers JE
    Cell Rep; 2022 Apr; 39(1):110598. PubMed ID: 35385738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An ALS-associated KIF5A mutant forms oligomers and aggregates and induces neuronal toxicity.
    Nakano J; Chiba K; Niwa S
    Genes Cells; 2022 Jun; 27(6):421-435. PubMed ID: 35430760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered molecular and cellular mechanisms in KIF5A-associated neurodegenerative or neurodevelopmental disorders.
    Cozzi M; Magri S; Tedesco B; Patelli G; Ferrari V; Casarotto E; Chierichetti M; Pramaggiore P; Cornaggia L; Piccolella M; Galbiati M; Rusmini P; Crippa V; Mandrioli J; Pareyson D; Pisciotta C; D'Arrigo S; Ratti A; Nanetti L; Mariotti C; Sarto E; Pensato V; Gellera C; Di Bella D; Cristofani RM; Taroni F; Poletti A
    Cell Death Dis; 2024 Sep; 15(9):692. PubMed ID: 39333504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ALS-related SOD1 mutants on dynein- and KIF5-mediated retrograde and anterograde axonal transport.
    Shi P; Ström AL; Gal J; Zhu H
    Biochim Biophys Acta; 2010 Sep; 1802(9):707-16. PubMed ID: 20510358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PP2A and GSK3 act as modifiers of FUS-ALS by modulating mitochondrial transport.
    Tziortzouda P; Steyaert J; Scheveneels W; Sicart A; Stoklund Dittlau K; Barbosa Correia AM; Burg T; Pal A; Hermann A; Van Damme P; Moens TG; Van Den Bosch L
    Acta Neuropathol; 2024 Feb; 147(1):41. PubMed ID: 38363426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splice-site mutations in KIF5A in the Japanese case series of amyotrophic lateral sclerosis.
    Naruse H; Ishiura H; Mitsui J; Takahashi Y; Matsukawa T; Sakuishi K; Nakamagoe K; Miyake Z; Tamaoka A; Goto J; Yoshimura J; Doi K; Morishita S; Toda T; Tsuji S
    Neurogenetics; 2021 Mar; 22(1):11-17. PubMed ID: 32815063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hot-spot KIF5A mutations cause familial ALS.
    Brenner D; Yilmaz R; Müller K; Grehl T; Petri S; Meyer T; Grosskreutz J; Weydt P; Ruf W; Neuwirth C; Weber M; Pinto S; Claeys KG; Schrank B; Jordan B; Knehr A; Günther K; Hübers A; Zeller D; Kubisch C; Jablonka S; Sendtner M; Klopstock T; de Carvalho M; Sperfeld A; Borck G; Volk AE; Dorst J; Weis J; Otto M; Schuster J; Del Tredici K; Braak H; Danzer KM; Freischmidt A; Meitinger T; Strom TM; Ludolph AC; Andersen PM; Weishaupt JH;
    Brain; 2018 Mar; 141(3):688-697. PubMed ID: 29342275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor neurons and glia exhibit specific individualized responses to TDP-43 expression in a Drosophila model of amyotrophic lateral sclerosis.
    Estes PS; Daniel SG; McCallum AP; Boehringer AV; Sukhina AS; Zwick RA; Zarnescu DC
    Dis Model Mech; 2013 May; 6(3):721-33. PubMed ID: 23471911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation analysis of KIF5A in Chinese amyotrophic lateral sclerosis patients.
    Zhang K; Liu Q; Shen D; Tai H; Liu S; Wang Z; Shi J; Fu H; Wu S; Ding Q; Hu Y; Wu Y; Li X; Guan Y; Liu M; Cui L; Zhang X
    Neurobiol Aging; 2019 Jan; 73():229.e1-229.e4. PubMed ID: 30301576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor neuron apoptosis and neuromuscular junction perturbation are prominent features in a Drosophila model of Fus-mediated ALS.
    Xia R; Liu Y; Yang L; Gal J; Zhu H; Jia J
    Mol Neurodegener; 2012 Mar; 7():10. PubMed ID: 22443542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial defect in muscle precedes neuromuscular junction degeneration and motor neuron death in CHCHD10
    Genin EC; Madji Hounoum B; Bannwarth S; Fragaki K; Lacas-Gervais S; Mauri-Crouzet A; Lespinasse F; Neveu J; Ropert B; Augé G; Cochaud C; Lefebvre-Omar C; Bigou S; Chiot A; Mochel F; Boillée S; Lobsiger CS; Bohl D; Ricci JE; Paquis-Flucklinger V
    Acta Neuropathol; 2019 Jul; 138(1):123-145. PubMed ID: 30874923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.
    Nicolas A; Kenna KP; Renton AE; Ticozzi N; Faghri F; Chia R; Dominov JA; Kenna BJ; Nalls MA; Keagle P; Rivera AM; van Rheenen W; Murphy NA; van Vugt JJFA; Geiger JT; Van der Spek RA; Pliner HA; Shankaracharya ; Smith BN; Marangi G; Topp SD; Abramzon Y; Gkazi AS; Eicher JD; Kenna A; ; Mora G; Calvo A; Mazzini L; Riva N; Mandrioli J; Caponnetto C; Battistini S; Volanti P; La Bella V; Conforti FL; Borghero G; Messina S; Simone IL; Trojsi F; Salvi F; Logullo FO; D'Alfonso S; Corrado L; Capasso M; Ferrucci L; ; Moreno CAM; Kamalakaran S; Goldstein DB; ; Gitler AD; Harris T; Myers RM; ; Phatnani H; Musunuri RL; Evani US; Abhyankar A; Zody MC; ; Kaye J; Finkbeiner S; Wyman SK; LeNail A; Lima L; Fraenkel E; Svendsen CN; Thompson LM; Van Eyk JE; Berry JD; Miller TM; Kolb SJ; Cudkowicz M; Baxi E; ; Benatar M; Taylor JP; Rampersaud E; Wu G; Wuu J; ; Lauria G; Verde F; Fogh I; Tiloca C; Comi GP; Sorarù G; Cereda C; ; Corcia P; Laaksovirta H; Myllykangas L; Jansson L; Valori M; Ealing J; Hamdalla H; Rollinson S; Pickering-Brown S; Orrell RW; Sidle KC; Malaspina A; Hardy J; Singleton AB; Johnson JO; Arepalli S; Sapp PC; McKenna-Yasek D; Polak M; Asress S; Al-Sarraj S; King A; Troakes C; Vance C; de Belleroche J; Baas F; Ten Asbroek ALMA; Muñoz-Blanco JL; Hernandez DG; Ding J; Gibbs JR; Scholz SW; Floeter MK; Campbell RH; Landi F; Bowser R; Pulst SM; Ravits JM; MacGowan DJL; Kirby J; Pioro EP; Pamphlett R; Broach J; Gerhard G; Dunckley TL; Brady CB; Kowall NW; Troncoso JC; Le Ber I; Mouzat K; Lumbroso S; Heiman-Patterson TD; Kamel F; Van Den Bosch L; Baloh RH; Strom TM; Meitinger T; Shatunov A; Van Eijk KR; de Carvalho M; Kooyman M; Middelkoop B; Moisse M; McLaughlin RL; Van Es MA; Weber M; Boylan KB; Van Blitterswijk M; Rademakers R; Morrison KE; Basak AN; Mora JS; Drory VE; Shaw PJ; Turner MR; Talbot K; Hardiman O; Williams KL; Fifita JA; Nicholson GA; Blair IP; Rouleau GA; Esteban-Pérez J; García-Redondo A; Al-Chalabi A; ; Rogaeva E; Zinman L; Ostrow LW; Maragakis NJ; Rothstein JD; Simmons Z; Cooper-Knock J; Brice A; Goutman SA; Feldman EL; Gibson SB; Taroni F; Ratti A; Gellera C; Van Damme P; Robberecht W; Fratta P; Sabatelli M; Lunetta C; Ludolph AC; Andersen PM; Weishaupt JH; Camu W; Trojanowski JQ; Van Deerlin VM; Brown RH; van den Berg LH; Veldink JH; Harms MB; Glass JD; Stone DJ; Tienari P; Silani V; Chiò A; Shaw CE; Traynor BJ; Landers JE
    Neuron; 2018 Mar; 97(6):1267-1288. PubMed ID: 29566793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misfolded SOD1 inclusions in patients with mutations in
    Forsberg K; Graffmo K; Pakkenberg B; Weber M; Nielsen M; Marklund S; Brännström T; Andersen PM
    J Neurol Neurosurg Psychiatry; 2019 Aug; 90(8):861-869. PubMed ID: 30992335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-Genome Sequencing Identified a Novel Mutation in the N-Terminal Domain of
    Wang H; Guan L; Ma X; Wang Y; Wang J; Zhang P; Deng M
    Genes (Basel); 2024 May; 15(6):. PubMed ID: 38927616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defects in synaptic transmission at the neuromuscular junction precede motor deficits in a TDP-43
    Chand KK; Lee KM; Lee JD; Qiu H; Willis EF; Lavidis NA; Hilliard MA; Noakes PG
    FASEB J; 2018 May; 32(5):2676-2689. PubMed ID: 29295857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.